Pulmonary Delivery as a Route for Insulin

Pandey, Shivanand and Choudhary, Amruta and Patel, Binal and Mahalaxmi, R and Devmurari, Viral and Jivani, NP (2009) Pulmonary Delivery as a Route for Insulin. International Journal of PharmTech Research, 1 (4). pp. 1190-1197. (Submitted)

[img] PDF
PT=36_(1190-1197).pdf - Published Version
Restricted to Registered users only

Download (266kB) | Request a copy


The pulmonary route of administration offers several advantages. First, the lung has a large surface area for drug absorption, ranging from 100 to 140 m2. In addition, the alveolar epithelium has permeability that allows for rapid absorption of solutes. Because the mucociliary clearance of the alveolar lung tissue is slower than that of the bronchiolar tissues, the alveoli provide a greater opportunity for the absorption of larger molecules (e.g., insulin). Studies have shown that particle size should be between 1 and 3 micrometers in diameter for optimal deposition in the lung, and that dry powder formulation can deliver more active drug in a single inhalation than liquid aerosol formulations. Patient-controlled variables (e.g., inhalation flow rate, inhaled volume, and duration of inhalation) also need to be controlled for optimal deep-lung insulin delivery. The pharmacodynamic effects of insulin formulations administered via the lung are comparable to, or even faster than, those of subcutaneous injected regular insulin or rapid-acting insulin analogues.

Item Type: Article
Uncontrolled Keywords: Transmembrane, Mucociliary, Liquid aerosol formulations, Inhalation,Insulin delivery
Subjects: Pharmacy > MCOPS Manipal > Pharmaceutics
Depositing User: KMC Manipal
Date Deposited: 09 Jan 2012 10:31
Last Modified: 09 Jan 2012 10:31
URI: http://eprints.manipal.edu/id/eprint/2252

Actions (login required)

View Item View Item